Responding appropriately to safety signals in infants exposed to the 6-month BDLLfx/BDLCfz regimen in utero. Loveday M, Clarence E, Brust JCM, Waitt C, et al. Clin Infect Dis 2026 Mar 3:ciag143. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Loveday M, Clarence E, Brust JCM, Waitt C, et al. Responding appropriately to safety signals in infants exposed to the 6-month BDLLfx/BDLCfz regimen in utero. Clin Infect Dis 2026 Mar 3:ciag143. doi: 10.1093.
PMID: 41774752